Objectives of the Study:

# To define, describe, and forecast the global cell isolation market based on the product, cell type, cell source, technique, application, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities).
# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.
# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
# To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
# To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
# To track and analyze competitive developments such as acquisitions, expansions, agreements, collaborations, and R&D activities in the market.

Growth Boosting Factors:

Various elements such as increasing government funding for cell-based research and the increasing number of patients suffering from cancer & infectious diseases, and the technological advancements, are driving the market growth.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Projected Growth in Revenue Growth:

According to revenue estimates, the global cell isolation market will be valued $4.4 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 13.4% from 2023 to 2028, when it reaches $8.2 billion.

Market Size Estimation

Top-down approach was used to estimate and validate the total size of the cell isolation market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and market have been identified through extensive secondary research.
# The revenues generated from the cell isolation products business of leading players have been determined through primary and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Consumables segment dominated the cell isolation market in 2022.

Based on product, the market is broadly segmented into consumables and instruments. In 2022, consumables accounted for the dominant share of the market. This segment's large share can be attributed to factors such as the repetitive use of consumables in the cell isolation. Furthermore, the increasing number of regulatory approvals of new consumables is likely to upsurge the growth of the segment.

The biomolecule isolation segment of cell isolation market is expected to grow at the highest CAGR during the forecast period.

Based on application, the market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment is expected to register the highest CAGR during the forecast period. Launch of advanced and new products is one of the factors driving the market growth.

Geographical Growth Dynamics:

North America dominated cell isolation market in 2022.

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa make up the geographical segments of the market. In terms of market share for cell isolation in 2022, North America was the largest, followed by Europe and the Asia-Pacific area. The majority of the American market is accounted for by a number of factors, including technological advancement, the growth of the biotechnology and pharmaceutical industries, and the rise in the prevalence of infectious and chronic diseases.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479

Global Leading Companies:

Some of the prominent players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).

Recent Developments:

# In October 2022, Thermo Fisher Scientific, Inc. launched DynaCellect, a next-generation cell isolation, cell activation, cell depletion instrument. It also launched the Dynabeads magnetic beads removal instrument to optimize the cell therapy manufacturing process.

# In June 2022, Terumo BCT and GenCure collaborated to advance cell and gene therapy manufacturing solutions.

# In May 2022, Terumo BCT inaugurated its second manufacturing facility in Colorado.

Inquiry Before Buying@
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1...

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]